Sfoglia per AUTORE
ROSSI E
Collezione AOU Novara

  

Items : 8

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours. in Journal of hepatology / J Hepatol. 2024 Mar;80(3):431-442. doi: 10.1016/j.jhep.2023.10.040. Epub 2023 Nov 15.

2024
AOU Novara
AO Alessandria

Pinato DJ; Cammà C; Cortellini A; Pinto C; Bersanelli M; Brunetti L; Sorarù M; Montesarchio V; Bordi P; Cavanna L; De Giorgi U; Russo A; Laera L; Ricciardi S; Grossi F; Banzi M; Pipitone S; Bordonaro R; Negrini G; Di Pietro FR; Battelli N; Ficorella C; Zustovich F; Rossi E; Verderame F; Ermacora P; Antonuzzo L; Veccia A; Catino A; et alii...

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes. in Annals of hematology / Ann Hematol. 2024 Feb;103(2):437-442. doi: 10.1007/s00277-023-05577-9. Epub 2023 Dec 7.

2024
AOU Novara
AOU Città della Salute di Torino

Bellini M; Finazzi MC; Rambaldi A; Tognoni G; Cattaneo D; Vianelli N; Scaffidi L; Bucelli C; Lunghi F; Ramundo F; Betti S; Gesullo F; Guglielmelli P; Calabresi L; Loscocco GG; Cacciola E; Cascavilla N; Mora B; Rumi E; Patriarca A; Siragusa S; Rapezzi D; Musolino C; Caramella M; Pane F; Ricco A; Carli G; Palandri F; Benevolo G; et alii...

The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study. in Cancers / Cancers (Basel). 2023 Mar 26;15(7):1980. doi: 10.3390/cancers15071980.

2023
AOU Novara

Depenni R; Marconcini R; Rossi E; Palleschi D; Morelli MF; Banzi M; Sponghini A; Consoli F; Troiani T; Rinaldi G; Minisini A; Quaglino P; Chiarion Sileni V; Del Vecchio M; Carnevale-Schianca F; Marcon I; Queirolo P;

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Mar;8(3):e175-e184. doi: 10.1016/S2352-3026(20)30373-2. Epub 2021 Jan 18.

2021
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Tognoni G; Finazzi MC; Bellini M; Bucelli C; Lunghi F; Vianelli N; Scaffidi L; Betti S; Guglielmelli P; Loscocco GG; Mora B; Cacciola E; Mannarelli C; Patriarca A; Cascavilla N; Rumi E; Siragusa S; Musolino C; Caramella M; Rapezzi D; Ricco A; Carli G; Palandri F; Pane F; Benevolo G; Bonifacio M; Iurlo A; Ciceri F; Ghirardi A; et alii...

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia. in Blood / Blood. 2021 Aug 19;138(7):571-583. doi: 10.1182/blood.2021010735.

2021
AOU Città della Salute di Torino
AOU Novara

Vianelli N; Zaja F; De Stefano V; Rodeghiero F; Mazzucconi MG; Cavo M; Sutto E; Carpenedo M; Carli G; Nicolosi D; Baldacci E; Auteri G; Borchiellini A; Giuffrida G; Caocci G; Chiurazzi F; Consoli U; Cantoni S; Oliva EN; Barcellini W; Patriarca A; Rivolti E; Carrai V; Bartoletti D; Ferretti A; Ruggeri M; Lucchini E; Palandri F; Rossi E; et alii...

Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study. in British journal of haematology / Br J Haematol. 2021 Apr;193(2):386-396. doi: 10.1111/bjh.17334. Epub 2021 Feb 22.

2021
AOU Città della Salute di Torino
AOU Novara

Zaja F; Fanin R; Rodeghiero F; Carpenedo M; Giardini I; Gigliotti CL; Boggio E; Dianzani U; Crea E; Vignetti M; Paoloni F; Santoro C; Barcellini W; Celli M; Consoli U; Valeri F; Carli G; Patriarca A; Rossi E; Auteri G; Vianelli N; Volpetti S; Palandri F; Lucchini E;

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study. in Blood / Blood. 2020 Jan 30;135(5):381-386. doi: 10.1182/blood.2019002614.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Di Veroli A; Vannucchi AM; Barbui T; Rambaldi A; Griesshammer M; Alvarez-Larran A; Isfort S; Marchetti M; McMullin MF; Tieghi A; Recasens V; Carli G; Cacciola R; Benevolo G; Fox ML; Beggiato E; Lunghi F; Angona A; Wille K; Perez-Encinas M; Erez D; Gomez M; Rapezzi D; Palova M; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; et alii...

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists. in Leukemia / Leukemia. 2016 Oct;30(10):2032-2038. doi: 10.1038/leu.2016.85. Epub 2016 Apr 26.

2016
AO Cuneo
AOU Novara

Barbui T; Vannucchi AM; Sant'Antonio E; Griesshammer M; Carobbio A; Musolino C; Rapezzi D; Forcina A; Pungolino E; Specchia G; Hernandez-Boluda JC; Tieghi A; Ellis MH; Cacciola R; Palova M; Cattaneo D; Nichele I; Betti S; Rossi E; Gaidano G; Zetterberg E; Vianelli N; Finazzi G; Finazzi MC; Elli E; Randi ML; Alvarez-Larrán A; Iurlo A; Ruggeri M; et alii...